Regenesis Biomedical, Inc.
PrivateLast Round
Series C
Jun 6, 2011
Est. Valuation
$30M
Total Funding Raised
$8.63M
Company Overview
Regenesis Biomedical, Inc. operates in Healthcare & Life Sciences and is based in Scottsdale, Arizona. Its latest recorded funding round was a Series C round in June 2011.
Regenesis Biomedical, Inc. is a medical device company that researches, designs, manufactures, and sells energy-based medical products for non-invasive pain management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement
Business Model
B2G
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenesis Biomedical, Inc. Comparables
Compare Regenesis Biomedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caerus Corp | 83% | |
| Electrome | 76% | |
| Zynex Inc | 71% |
For institutional investors. Book with your work email.
Regenesis Biomedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 6, 2011 | ||||
| Series B | Sep 5, 2006 | ||||
| Series A | Apr 26, 2002 |
For institutional investors. Book with your work email.
Regenesis Biomedical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Solstice Capital | Series C, Series A |
| Tucson Ventures | Series A |
| TGap Ventures | Series C |
| Village Ventures | Series A |
| Fulcrum Equity Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 6, 2011
$5.3M round led by TGap Ventures and Fulcrum Equity Partners.
- Sep 5, 2006
$528K round completed.
For institutional investors. Book with your work email.
Regenesis Biomedical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenesis Biomedical, Inc.'s valuation, stock price, and market status.
Is Regenesis Biomedical, Inc. a public or private company?
Regenesis Biomedical, Inc. is a private company.
What is the current stock price of Regenesis Biomedical, Inc.?
Regenesis Biomedical, Inc. is a private company, so its shares have no public market price. Caplight tracks Regenesis Biomedical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenesis Biomedical, Inc. worth (valuation)?
Regenesis Biomedical, Inc.'s valuation is estimated at $30.0M based on funding round data.
Can I buy Regenesis Biomedical, Inc. stock?
Regenesis Biomedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenesis Biomedical, Inc.'s last funding round?
Regenesis Biomedical, Inc.'s most recent funding round was Series C on June 6, 2011.
Who are the main investors in Regenesis Biomedical, Inc.?
Key investors in Regenesis Biomedical, Inc. include TGap Ventures, Fulcrum Equity Partners.
Will Regenesis Biomedical, Inc. IPO soon?
No public IPO plans have been announced for Regenesis Biomedical, Inc..
How can I track Regenesis Biomedical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Regenesis Biomedical, Inc.'s shares on secondary markets.